- Home
- CEE vs VNRX Comparison
CEE vs VNRX Comparison
Compare CEE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- VNRX
- Stock Information
- Founded
- CEE 1990
- VNRX N/A
- Country
- CEE Germany
- VNRX United States
- Employees
- CEE N/A
- VNRX N/A
- Industry
- CEE Finance Companies
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CEE Finance
- VNRX Health Care
- Exchange
- CEE Nasdaq
- VNRX Nasdaq
- Market Cap
- CEE 79.2M
- VNRX 67.2M
- IPO Year
- CEE N/A
- VNRX N/A
- Fundamental
- Price
- CEE $11.97
- VNRX $0.66
- Analyst Decision
- CEE
- VNRX Strong Buy
- Analyst Count
- CEE 0
- VNRX 4
- Target Price
- CEE N/A
- VNRX $4.17
- AVG Volume (30 Days)
- CEE 22.0K
- VNRX 586.6K
- Earning Date
- CEE 01-01-0001
- VNRX 11-14-2024
- Dividend Yield
- CEE 3.86%
- VNRX N/A
- EPS Growth
- CEE N/A
- VNRX N/A
- EPS
- CEE N/A
- VNRX N/A
- Revenue
- CEE N/A
- VNRX $1,285,827.00
- Revenue This Year
- CEE N/A
- VNRX $180.66
- Revenue Next Year
- CEE N/A
- VNRX $558.69
- P/E Ratio
- CEE N/A
- VNRX N/A
- Revenue Growth
- CEE N/A
- VNRX 97.50
- 52 Week Low
- CEE $7.80
- VNRX $0.43
- 52 Week High
- CEE $10.32
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- CEE 53.41
- VNRX 52.35
- Support Level
- CEE $11.16
- VNRX $0.57
- Resistance Level
- CEE $12.26
- VNRX $0.68
- Average True Range (ATR)
- CEE 0.44
- VNRX 0.08
- MACD
- CEE -0.07
- VNRX 0.00
- Stochastic Oscillator
- CEE 60.45
- VNRX 82.35
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.